Bright Minds Biosciences, Inc. (DRUG)
51.58
-0.42
(-0.81%)
USD |
NASDAQ |
Oct 08, 13:30
Bright Minds Biosciences Price : 51.58 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 47.23 | 53.01 | 47.23 | 52.00 | 688820.0 |
| Oct 06, 2026 | 49.79 | 50.00 | 47.60 | 48.25 | 107660.0 |
| Oct 05, 2026 | 50.69 | 51.34 | 49.08 | 49.79 | 55951.00 |
| Oct 02, 2026 | 49.61 | 51.04 | 48.75 | 50.69 | 154901.0 |
| Oct 01, 2026 | 49.54 | 52.12 | 48.53 | 49.21 | 166987.0 |
| Sep 30, 2026 | 50.00 | 50.96 | 49.01 | 49.82 | 79829.00 |
| Sep 29, 2026 | 53.16 | 53.16 | 49.53 | 49.74 | 96761.00 |
| Sep 28, 2026 | 52.69 | 52.69 | 49.55 | 51.66 | 91879.00 |
| Sep 25, 2026 | 53.33 | 54.36 | 51.41 | 51.80 | 210973.0 |
| Sep 24, 2026 | 57.91 | 58.30 | 52.90 | 53.51 | 129658.0 |
| Sep 23, 2026 | 60.44 | 60.44 | 56.50 | 57.92 | 90379.00 |
| Sep 22, 2026 | 60.36 | 62.45 | 60.15 | 60.67 | 65268.00 |
| Sep 21, 2026 | 61.98 | 61.98 | 59.18 | 59.46 | 91656.00 |
| Sep 18, 2026 | 61.31 | 62.11 | 60.48 | 60.98 | 142387.0 |
| Sep 17, 2026 | 60.18 | 62.26 | 59.89 | 61.55 | 67351.00 |
| Sep 16, 2026 | 60.22 | 61.08 | 57.58 | 59.11 | 97446.00 |
| Sep 15, 2026 | 61.90 | 61.90 | 59.24 | 60.22 | 58990.00 |
| Sep 14, 2026 | 63.30 | 63.90 | 62.83 | 63.38 | 42154.00 |
| Sep 11, 2026 | 66.25 | 66.25 | 62.42 | 63.18 | 129222.0 |
| Sep 10, 2026 | 63.98 | 66.00 | 63.19 | 65.00 | 86709.00 |
| Sep 09, 2026 | 66.54 | 67.76 | 64.74 | 65.06 | 43212.00 |
| Sep 08, 2026 | 65.07 | 67.77 | 64.30 | 66.91 | 65213.00 |
| Sep 04, 2026 | 67.84 | 69.06 | 64.53 | 65.16 | 93013.00 |
| Sep 03, 2026 | 71.95 | 71.97 | 67.25 | 68.02 | 131268.0 |
| Sep 02, 2026 | 71.42 | 73.33 | 70.86 | 71.12 | 67013.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 405.70 |
| Lineage Cell Therapeutics, Inc. | 1.03 |
| Recursion Pharmaceuticals, Inc. | 3.84 |
| Agenus, Inc. | 7.61 |
| BioCryst Pharmaceuticals, Inc. | 8.28 |
Price Related Metrics
| PEG Ratio | -0.2059 |
| Price to Book Value | 2.345 |
| Earnings Yield | -4.04% |
| Market Cap | 508.79M |
| PEGY Ratio | -0.2059 |